Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Insurer Chubb to acquire Cigna's business in Asia, Turkey for $5.8 billion

Published 10/07/2021, 09:58 PM
Updated 10/08/2021, 01:20 AM
© Reuters. FILE PHOTO: A screen displays the logo fro Cigna Corp. on the floor at the New York Stock Exchange (NYSE) in New York, U.S., July 16, 2019. REUTERS/Brendan McDermid

SINGAPORE (Reuters) -U.S. insurer Chubb (NYSE:CB) Ltd has agreed to buy health insurer Cigna Corp (NYSE:CI)'s life, accident, and supplemental benefits businesses in Asia Pacific and Turkey for $5.75 billion in cash, both insurers said, marking the latest consolidation in Asia's insurance sector.

In a statement issued late on Thursday, Chubb said it will acquire Cigna's A&H (accident and health) and life business in South Korea, Taiwan, New Zealand, Thailand, Hong Kong and Indonesia, in addition to Cigna's 51% stake in a joint venture in Turkey.

"The addition of Cigna's business, which is overwhelmingly A&H (accident and health), will rebalance our global portfolio towards this important region," Chubb CEO Evan Greenberg said.

Chubb said the acquisition will boost Asia's share of its global portfolio to $7 billion from about $4 billion in net premiums written, representing about 20% of the company's total business, excluding China.

The transaction comes at a time of a shakeup in the insurance sector in key markets.

In August, HSBC Holdings (NYSE:HSBC) agreed to acquire https://www.reuters.com/world/asia-pacific/hsbc-buy-axas-insurance-assets-singapore-575-mln-2021-08-16 French insurer Axa's Singapore assets for $575 million.

Last year, Singapore Life, an upstart insurer backed by investors including buyout group TPG, acquired the Singapore business of British insurer Aviva (LON:AV) https://www.reuters.com/article/us-aviva-gb-divestiture-idUSKBN26225B for nearly $2 billion, as it expands in Southeast Asia.

Cigna said Chubb will acquire Cigna's business in South Korea and continue to operate it under the LINA Korea brand.

Cigna will focus on its global health services portfolio, as well as local market services in the Middle East, Europe, Hong Kong, Singapore and its joint ventures in Australia, China and India.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The deal is not subject to a financing condition and Cigna expects to realize about $5.4 billion of net after-tax proceeds.

The transaction, subject to regulatory approvals, is expected to be completed in 2022.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.